Our latest moves.

Announcements, peer-reviewed publications, and press coverage of the AVATAR platform and the science behind it.

• Announcements

  Cavatar emerges from PRISM to advance caveolae-targeting antibodies

  Cavatar
  2026
• Publications

  Aminopeptidase P2 is a lung caveolae-enriched protein that can be targeted for pulmonary delivery.

  Nature Nanotechnology
  2025
• Publications

  Anti-TGF-beta bispecific antibody for pulmonary fibrosis treatment.

  PLOS ONE
  2022
• Publications

  Caveolae-mediated transcytosis can be targeted with a caveolae-targeting antibody to truncated Annexin A1 for noninvasive delivery to tumors.

  Nature Medicine
  2014
• Publications

  Aminopeptidase P2 is a lung caveolae-enriched protein that can be targeted for pulmonary delivery.

  Journal of Vascular Research
  2010
• Publications

  Impaired tumor growth, metastasis, angiogenesis, and wound healing in Annexin A1-null mice — foundational biology behind the AnnA1 program.

  Proceedings of the National Academy of Sciences
  2009
• Publications

  Caveolae-mediated transcytosis can be induced in cells lacking caveolae.

  Nature Biotechnology
  2007
• Publications

  Caveolae-mediated transcytosis of antibody targeting caveolae.

  Nature
  2004